Pirkko-Liisa Kellokumpu-Lehtinen Selected Research

Pirkko-Liisa Kellokumpu-Lehtinen Research Topics

Disease

54	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2006
38	Neoplasms (Cancer) 01/2023 - 02/2006
21	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 03/2012
10	Unilateral Breast Neoplasms 05/2022 - 03/2015
7	Neoplasm Metastasis (Metastasis) 11/2019 - 01/2007
6	Disease Progression 04/2020 - 10/2011
6	Renal Cell Carcinoma (Grawitz Tumor) 10/2019 - 02/2008
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2017 - 08/2011
4	Heart Failure 07/2023 - 02/2006
4	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 11/2019
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2014 - 08/2011
2	Fibrosis (Cirrhosis) 07/2023 - 06/2021
2	Triple Negative Breast Neoplasms 07/2021 - 06/2017
2	Cardiotoxicity 02/2020 - 12/2017
2	Febrile Neutropenia 12/2019 - 12/2009
2	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2018 - 07/2015
2	Hyperthermia 01/2018 - 02/2016
2	Neutropenia 12/2015 - 12/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 07/2015 - 09/2013
2	Melanoma (Melanoma, Malignant) 10/2011 - 01/2007
1	Diarrhea 01/2024
1	Fatigue 01/2024
1	Pain (Aches) 08/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Margins of Excision 11/2019
1	Extranodal Extension 11/2019
1	Non-ST Elevated Myocardial Infarction 03/2018

Drug/Important Bio-Agent (IBA)

19	Docetaxel (Taxotere)FDA Link 08/2022 - 02/2006
13	Trastuzumab (Herceptin)FDA Link 01/2021 - 02/2006
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2007
7	Estrogen ReceptorsIBA 01/2022 - 08/2014
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 02/2006
7	Capecitabine (Xeloda)FDA Link 01/2022 - 12/2006
7	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 02/2006
7	Vinorelbine (Navelbine)FDA LinkGeneric 07/2021 - 02/2006
6	taxaneIBA 03/2024 - 12/2009
6	CytokinesIBA 01/2019 - 01/2007
6	human ERBB2 proteinIBA 01/2018 - 12/2009
5	Bevacizumab (Avastin)FDA Link 03/2024 - 10/2011
5	Messenger RNA (mRNA)IBA 01/2023 - 04/2015
5	Hormones (Hormone)IBA 01/2023 - 03/2012
5	AnthracyclinesIBA 01/2022 - 12/2006
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2015
5	Fluorouracil (Carac)FDA LinkGeneric 02/2014 - 02/2006
4	Interleukin-6 (Interleukin 6)IBA 04/2023 - 08/2015
4	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 08/2011
3	Aromatase InhibitorsIBA 04/2024 - 03/2015
3	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2016
3	Prostate-Specific Antigen (Semenogelase)IBA 11/2019 - 02/2013
3	InterferonsIBA 01/2018 - 05/2010
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2021
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2021
2	LipidsIBA 01/2021 - 08/2014
2	Sunitinib (Sutent)FDA Link 10/2019 - 02/2008
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 03/2010
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2014
2	Interleukin-2 (IL2)IBA 01/2018 - 02/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 07/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2024
1	Neuropilin-1IBA 03/2024
1	abemaciclibIBA 01/2024
1	Carcinoembryonic AntigenIBA 04/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 08/2021
1	Immunoglobulins (Immunoglobulin)IBA 07/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	cabazitaxel FDA Link 12/2020
1	AndrogensIBA 12/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2019
1	Tyrosine Kinase InhibitorsIBA 10/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2019
1	InterleukinsIBA 01/2019
1	AntiemeticsIBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Aprepitant (Emend)FDA Link 01/2019
1	AntigensIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	LectinsIBA 01/2019
1	P-2 (P 2)IBA 11/2018
1	Chemotactic FactorsIBA 01/2018
1	LigandsIBA 01/2018
1	ChemokinesIBA 01/2018

Therapy/Procedure

31	Radiotherapy 01/2024 - 09/2013
29	Therapeutics 01/2024 - 02/2008
25	Drug Therapy (Chemotherapy) 03/2024 - 12/2006
11	Adjuvant Radiotherapy 01/2021 - 03/2015
9	Castration 01/2023 - 02/2013
8	Adjuvant Chemotherapy 04/2023 - 12/2009
3	Aftercare (After-Treatment) 01/2024 - 11/2011
2	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 11/2019
1	Immunotherapy 01/2023
1	Brachytherapy 01/2023
1	Palliative Care (Palliative Therapy) 01/2023
1	Metastasectomy 03/2022
1	Precision Medicine 08/2021
1	Combination Drug Therapy (Combination Chemotherapy) 07/2019
1	Length of Stay 03/2018